[Asia Economy Reporter Yoo Byung-don] Solgo Bio announced on the 28th that it has decided to issue the 11th series of unnamed subordinated unsecured convertible bonds (CB) worth 3 billion KRW. The purpose of issuing the convertible bonds is to raise operating funds.


The nominal interest rate and maturity interest rate are 3% and 5%, respectively. The conversion price is 500 KRW, and the conversion ratio is 100%. The bond maturity date is April 28, 2024.



The conversion target is Solgo Biomedical registered common shares, totaling 6 million shares. The conversion request period is from April 28, 2022, to March 28, 2024.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing